dc.contributor.author | Melia, J | |
dc.contributor.author | Coulson, P | |
dc.contributor.author | Coleman, D | |
dc.contributor.author | Moss, S | |
dc.date.accessioned | 2018-08-30T13:50:36Z | |
dc.date.issued | 2008-04-01 | |
dc.identifier | 7 | |
dc.identifier.citation | BRITISH JOURNAL OF CANCER, 2008, 98 pp. 1176 - 1181 | |
dc.identifier.issn | 0007-0920 | |
dc.identifier.uri | https://repository.icr.ac.uk/handle/internal/2467 | |
dc.identifier.doi | 10.1038/sj.bjc.6604291 | |
dc.description.abstract | The Prostate Cancer Risk Management Programme (PCRMP) launched in November 2002 provides guidelines for general practitioners (GPs) on age-specific prostate-specific antigen (PSA) cutoff levels in asymptomatic men. The impact of the PCRMP on GP referrals is unknown. This study investigates whether there was a change in the proportion of asymptomatic men with raised PSA levels (>= 3 ngml(-1)) who were referred to urologists since the launch of the guidelines. Sixty-nine general practices in four areas of England and the main pathology laboratory in each area, which had participated in our previous research, were asked to provide data. Forty-eight practices (70%) provided retrospective data on urological referrals in men who had a PSA test taken in the periods 1 December 2001 to 31 May 2002 (pre-launch) and 1 December 2003 to 31 May 2004 (post-launch). Data on referrals were completed for 709 (79%) out of 898 and 1040 (90%) out of 1157 raised records pre-and post-launch, respectively. The percentage of men with raised PSA levels who were asymptomatic was similar in both time periods (19 -20%) and the proportion referred to urologists according to the PCRMP guidelines did not increase significantly over time (24% pre-launch and 29% post-launch, P = 0.42). The referral rate was lower than expected if the guidelines had been followed. The influence of the guidelines seems to have been low. At the time of data collection, 56% (112 out of 200) of GP partners reported that they were aware of receiving the PCRMP pack. To ensure future, effective implementation of guidelines requires evaluation. | |
dc.format.extent | 1176 - 1181 | |
dc.language | eng | |
dc.language.iso | eng | |
dc.publisher | NATURE PUBLISHING GROUP | |
dc.rights.uri | https://creativecommons.org/licenses/by/4.0 | |
dc.title | Urological referral of asymptomatic men in general practice in England | |
dc.type | Journal Article | |
rioxxterms.versionofrecord | 10.1038/sj.bjc.6604291 | |
rioxxterms.licenseref.uri | https://creativecommons.org/licenses/by/4.0 | |
rioxxterms.licenseref.startdate | 2008-04-01 | |
rioxxterms.type | Journal Article/Review | |
dc.relation.isPartOf | BRITISH JOURNAL OF CANCER | |
pubs.notes | affiliation: Melia, J (Reprint Author), Inst Canc Res, Epidemiol Sect, Canc Screening Evaluat Unit, Sir Richard Doll Bldg,Cotswold Rd, Sutton SM2 5NG, Surrey, England. Melia, J.; Coulson, P.; Coleman, D.; Moss, S., Inst Canc Res, Epidemiol Sect, Canc Screening Evaluat Unit, Sutton SM2 5NG, Surrey, England. keywords: primary health care; hospital referral; health education; prostate-specific antigen keywords-plus: PROSTATE-SPECIFIC ANTIGEN; CANCER; TRIAL; PSA research-areas: Oncology web-of-science-categories: Oncology author-email: [email protected] funding-acknowledgement: Medical Research Council [G0501019] number-of-cited-references: 11 times-cited: 10 usage-count-last-180-days: 0 usage-count-since-2013: 2 journal-iso: Br. J. Cancer doc-delivery-number: 282IF unique-id: ISI:000254560400004 oa: green_published da: 2018-08-30 | |
pubs.notes | Not known | |
pubs.organisational-group | /ICR | |
pubs.organisational-group | /ICR/Primary Group | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Closed research teams | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Closed research teams/Cancer Screening Evaluation Unit (DoH) | |
pubs.organisational-group | /ICR | |
pubs.organisational-group | /ICR/Primary Group | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Closed research teams | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Closed research teams/Cancer Screening Evaluation Unit (DoH) | |
pubs.volume | 98 | |
pubs.embargo.terms | Not known | |
icr.researchteam | Cancer Screening Evaluation Unit (DoH) | en_US |
dc.contributor.icrauthor | Moss, Susan Mary | en |